NCT06314958View on ClinicalTrials.gov

Stage II/III Colorectal Cancer Recurrence

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

June 18, 2026

Study Completion Date

June 18, 2026

Conditions
Colorectal CancerColorectal AdenocarcinomaColorectal Cancer Stage IIColorectal Cancer Stage IIIColorectal Cancer Recurrent
Interventions
OTHER

CENSURE

A panel of CpG sites, whose methylation level is tested in macro-dissected formalin-fixed and paraffin-embedded (FFPE) samples derived from the primary tumor.

Trial Locations (4)

91016

RECRUITING

City of Hope Medical Center, Monrovia

Unknown

RECRUITING

Second Affiliated Hospital of Dalian Medical University, Dalian

RECRUITING

Barcelona University, Barcelona

RECRUITING

La Paz University Hospital, Madrid

All Listed Sponsors
lead

City of Hope Medical Center

OTHER